|
Market Closed -
Bombay S.E.
14:02:30 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,464.20 INR | -1.03% |
|
+3.25% | +21.04% |
| Market Cap | 697B 7.34B 6.33B 5.96B 5.43B 10.21B 10.28B 70.59B 27.43B 355B 27.57B 26.97B 1,176B | P/E 2027 * |
30x | P/E 2028 * | 25x |
|---|---|---|---|---|---|
| Enterprise Value | 661B 6.96B 6B 5.65B 5.15B 9.67B 9.74B 66.89B 25.99B 336B 26.13B 25.56B 1,115B | EV / Sales 2027 * |
3.93x | EV / Sales 2028 * | 3.47x |
| Free-Float |
51.04% | Yield 2027 * |
0.15% | Yield 2028 * | 0.16% |
Last Transcript : Glenmark Pharmaceuticals Limited
| 1 day | -1.03% | ||
| 1 week | +3.25% | ||
| Current month | -1.03% | ||
| 1 month | +10.34% | ||
| 3 months | +8.35% | ||
| 6 months | +15.27% | ||
| Current year | +21.04% |
| 1 week | 2,385.75 |  | 2,536.85 |
| 1 month | 2,163 | | 2,536.85 |
| Current year | 1,842.8 | | 2,536.85 |
| 1 year | 1,794 | | 2,536.85 |
| 3 years | 702.05 | | 2,536.85 |
| 5 years | 348.9 | | 2,536.85 |
| 10 years | 168 | | 2,536.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.03% | +3.25% | - | - | 7.36B | |
| -2.81% | +0.99% | +20.98% | +73.53% | 50.05B | |
| +1.14% | +1.47% | +59.54% | +123.40% | 40.29B | |
| +0.56% | +5.80% | +19.04% | +86.59% | 12.17B | |
| +0.98% | -1.04% | -10.47% | +13.15% | 11.96B | |
| +0.57% | +2.72% | +31.59% | +153.11% | 9.25B | |
| -0.15% | -1.65% | +27.65% | +48.56% | 7.62B | |
| -0.39% | +3.33% | +28.41% | +222.15% | 7.36B | |
| +1.43% | +1.70% | +50.00% | -9.99% | 7.21B | |
| -0.13% | +0.79% | -36.70% | +15.26% | 5.26B | |
| Average | +0.02% | +1.16% | +21.11% | +80.64% | 16.8B | |
| Weighted average by Cap. | -0.46% | +1.81% | +29.33% | +87.93% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.77B 1.53B 1.43B 1.31B 2.46B 2.48B 17B 6.61B 85.4B 6.64B 6.5B 283B | 187B 1.97B 1.7B 1.6B 1.46B 2.74B 2.76B 18.95B 7.36B 95.16B 7.4B 7.24B 316B |
| Net income | 23.11B 243M 210M 197M 180M 338M 341M 2.34B 909M 11.75B 914M 894M 39B | 27.71B 292M 252M 237M 216M 406M 408M 2.81B 1.09B 14.09B 1.1B 1.07B 46.75B |
| Net Debt | -36.49B -384M -331M -312M -284M -534M -538M -3.69B -1.44B -18.56B -1.44B -1.41B -61.57B | -48B -506M -436M -410M -374M -703M -708M -4.86B -1.89B -24.41B -1.9B -1.86B -81B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | ₹2,464.20 | -1.03% | 17,692 |
| 31/08/26 | ₹2,489.85 | -1.09% | 38,805 |
| 28/08/26 | ₹2,517.40 | +2.50% | 19,900 |
| 27/08/26 | ₹2,456.00 | +0.66% | 17,019 |
| 26/08/26 | ₹2,440.00 | +1.88% | 12,072 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
